Prostate Cancer
Immortal human prostate epithelial cell line established
Published in Gene Therapy Weekly, June 30th, 2005
"The generation of suitable in vitro models is critical for understanding the process associated with the development and progression of prostate cancer in high-risk African-American men.
"However, the generation of long-term human prostate epithelial cell lines derived from primary human prostate epithelium have been unsuccessful due to the absence of in vitro immortalization," scientists in the United States report.
"We have successfully established an immortal human prostate epithelial cell line from primary benign tissues of African-American prostate cancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-06-30)
More Articles from Gene Therapy Weekly
- Biotechnology
HuMax-CD20 effective in killing tumor cells with very low levels of CD20 - Bone Regeneration
Gene therapy enhances osteogenesis - Diagnostics
Genetic and epigenetic alterations of PTEN gene in soft tissue sarcomas studied - Hemophilia
Researchers demonstrate long-term therapeutic gene therapy for HA in dogs - Neuropathy
Gene transfer technology, common virus used to block neuropathic pain - Addiction Medicine
Developing lung studied, expression and modulation of lynx1 clarified - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
